DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

A burgeoning state program to incentivize progressive zoning could make a significant impact on the development of workforce ...

This transaction may be completed online. Retirement Online gives you an easy and secure way to review your benefits and conduct transactions in real time instead of sending forms through the mail or ...

(ix) We do not for a moment say that, the Closest Connection Test has no application whatsoever, where there is no express or ...

Lehigh Valley Economic Development Corp. said Tuesday it submitted an application to the U.S ... according to the news release. A designation could qualify the region for $50 to $75 million ...

(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received rare pediatric disease ...

Cancer care designations serve as a way to distinguish the research, clinical services, and cancer prevention efforts taking place at a cancer center, hospital or health system. Here is a non ...

He was the district manager for the Hercules Powder Co., according to the application for historic designation. The next significant owners were Frank and Herma Weeks. Frank Weeks owned and ...

Andrew Forgrave was recognized at the 2024 ASPPA Annual conference as achieving the FSEA designation, an advanced fellowship designation that is a respected form of recognition for actuaries.

--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to volixibat as a ...

WWE announced the first five independent wrestling schools to receive the WWE ID designation: Booker T’s “Reality of Wrestling” in Houston, TX, Cody Rhodes’ “Nightmare Factory” in ...

- Designation based on positive interim analysis of Phase 2b VANTAGE study "Breakthrough Therapy Designation for volixibat in PBC underscores the importance and urgency for a treatment to address ...